Search

Your search keyword '"Lempinen, Marko"' showing total 216 results
Start Over Author "Lempinen, Marko"
216 results on '"Lempinen, Marko"'

11. The first 10 years of simultaneous pancreas‐kidney transplantation in Finland

Author

Ahopelto, Kaisa, primary, Sallinen, Ville, additional, Helanterä, Ilkka, additional, Bonsdorff, Akseli, additional, Grasberger, Juulia, additional, Beilmann‐Lehtonen, Ines, additional, Mäkisalo, Heikki, additional, Nordin, Arno, additional, Ortiz, Fernanda, additional, Savikko, Johanna, additional, Tukiainen, Eija, additional, Uutela, Aki, additional, Ekstrand, Agneta, additional, and Lempinen, Marko, additional

Published
2023
Full Text
View/download PDF

13. Pasireotide Versus Octreotide in Preventing Complications After Simultaneous Pancreas-Kidney Transplantation.

Author

Ahopelto, Kaisa, Bonsdorff, Akseli, Grasberger, Juulia, Lempinen, Marko, Nordin, Arno, Helanterä, Ilkka, and Sallinen, Ville

Subjects
KIDNEY transplantation, PANCREATIC surgery, ELECTIVE surgery, SURGICAL complications, PANCREAS transplantation, REOPERATION, PANCREAS
Abstract

In elective pancreatic surgery, somatostatin-analogues pasireotide and octreotide are variably used to reduce postoperative complications, but knowledge on their role in pancreas transplantation is limited. This study compared pasireotide and octreotide for their association with complications after simultaneous pancreas-kidney transplantation (SPK). This retrospective study included consecutive patients undergoing SPK’s from July 2013 to July 2022. Between July 2013 and April 2020, octreotide was administered 0.1 mg s.c. once daily and between May 2020 and July 2022 pasireotide was administered 0.9 mg twice daily, both until third postoperative day. Complications within 90 days postoperatively were collected, and reoperation rate and Comprehensive Complication index (CCI) ≥ 33.7 (morbidity equal to one reoperation) were used as primary outcomes. Of the 213 patients undergoing SPK, 150 patients received octreotide and 63 pasireotide. Baseline characteristics were comparable. Reoperation rate was 25.3% (n = 38) and 17.5% (n = 11) (p = 0.213) and rate of CCI ≥ 33.7 was 40.7% (n = 61) and 30.2% (n = 19) (p = 0.148) in octreotide and pasireotide groups, respectively. When adjusted with donor BMI, pancreas donor risk index, and donor sex, receiving pasireotide translated into OR 0.49 (95% CI: 0.25–0.96 p = 0.037) for CCI ≥ 33.7. Pasireotide was independently associated with lower postoperative morbidity within 90 days of SPK compared to octreotide. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

14. Timing of Organ Procurement From Brain-Dead Donors Associates With Short- and Long-Term Outcomes After Liver Transplantation

Author

Eerola, Verner, Helanterä, Ilkka, Åberg, Fredrik, Lempinen, Marko, Mäkisalo, Heikki, Nordin, Arno, Isoniemi, Helena, Sallinen, Ville, Clinicum, HUS Abdominal Center, IV kirurgian klinikka, Pertti Panula / Principal Investigator, Department of Anatomy, and Helsinki University Hospital Area

Subjects
organ allocation, liver allograft function, Transplantation, Tissue and Organ Procurement, DURATION, graft survival, liver transplant dysfunction, Brain, donor hepatectomy, 3126 Surgery, anesthesiology, intensive care, radiology, Severity of Illness Index, Liver Transplantation, TIME, End Stage Liver Disease, ACTIVATION, procurement surgery, SURVIVAL, Humans, brain death, FAILURE
Abstract

Brain death-induced cytokine storm is thought to harm transplantable organs. However, longer procurement times have been associated with non-inferior or better outcomes in kidney, heart, and lung transplants, while optimal procurement time for liver allografts is unknown. Our aim was to analyze the association of time interval from brain death to organ procurement with liver allograft outcomes in two nationwide cohorts. The association of procurement interval with graft survival and short-term complications was analysed in multivariable models. Altogether 643 and 58,017 orthotopic liver transplantations from brain-dead donors were included from Finland between June 2004 and December 2017 and the US between January 2008 and August 2018, respectively. Median time from brain death to organ procurement was 10.5 h in Finland and 34.6 h in the US. Longer interval associated with better graft survival (non-linearly, p = 0.016) and less acute rejections (OR 0.935 95% CI 0.894–0.978) in the US cohort, and better early allograft function (p = 0.005; Beta −0.048 95% CI −0.085 −(−0.011)) in the Finnish cohort, in multivariable models adjusted with Donor Risk Index, recipient age, Model for End-Stage Liver Disease and indication for transplantation. Progressive liver injury after brain death is unlikely. Rushing to recover seems unnecessary; rest and repair might prove beneficial.

Published
2022

22. Elinluovutus kuoleman jälkeen

Author

Koivusalo, Anna-Maria, Nordin, Arno, Lempinen, Marko, Ulander, Veli-Matti, Ala-Kokko, Tero, HUS Leikkaussalit, teho- ja kivunhoito, HUS Vatsakeskus, and IV kirurgian klinikka

Subjects
Death, Brain Death, 3126 Kirurgia, anestesiologia, tehohoito, radiologia, +legislation & jurisprudence, Organ Transplantation, Unrelated Donors, Tissue Donors
Abstract

Vertaisarvioitu. English summary. • Elinsiirrot ovat kustannustehokasta hoitoa. Niitä rajoittaa elinluovuttajien määrä ja siirrännäisten puute. • Elinsiirto- ja -luovutustoimintaa säädellään ja valvotaan tarkkaan lailla. • Luovuttajien määrää on yritetty lisätä lainsäädännöllä ja toimintaa koordinoimalla. • Kuolleet elinluovuttajat Suomessa ovat olleet aivokuolleita. • Monissa maissa on käytössä elinluovutus verenkierron pysähtymisen ja kuoleman toteamisen jälkeen -toiminta. Se mahdollistaa elinluovutuksen potilaalta, jolla on palautumaton aivovaurio mutta tila ei etene aivokuolemaan. Tämä toiminta on tarkoitus aloittaa myös Suomessa.

Published
2021

28. Munuaisensiirto elävältä luovuttajalta

Author

Helanterä, Ilkka, Ahopelto, Kaisa, Lempinen, Marko, HUS Vatsakeskus, Nefrologian yksikkö, IV kirurgian klinikka, and Kirurgian osasto

Subjects
Transplantation Conditioning, Risk Factors, 3126 Kirurgia, anestesiologia, tehohoito, radiologia, Living Donors, Kidney Transplantation, Tissue Donors
Abstract

Teema : elinsiirrot Munuaisensiirtoja elävältä luovuttajalta on Suomessa perinteisesti tehty vain vähän, mutta niiden määrää on viime vuosina pyritty lisäämään. Uusi kudoslaki mahdollistaa yhä useamman toimimisen elävänä luovuttajana. Munuaisluovuttajan riskit ovat vähäiset ja nykyään erittäin hyvin tunnetut.

Published
2020

29. Mitä uutta elinsiirtorintamalla?

Author

Lempinen, Marko, Ahopelto, Kaisa, Sallinen, Ville, HUS Vatsakeskus, IV kirurgian klinikka, Kirurgian osasto, Clinicum, Pertti Panula / Vastuullinen tutkija, and Anatomian osasto

Subjects
Cryopreservation, Ischemia, 3126 Kirurgia, anestesiologia, tehohoito, radiologia, Transplants, Organ Transplantation, Heart Arrest
Abstract

Teema : elinsiirrot

Published
2020

30. Enemmän elinsiirtoja verenkierron pysähtymisen jälkeisillä elinluovutuksilla

Author

Lempinen, Marko, Koivusalo, Anna-Maria, IV kirurgian klinikka, HUS Vatsakeskus, Diagnostis-terapeuttinen osasto, Clinicum, and HUS Leikkaussalit, teho- ja kivunhoito

Subjects
Tissue and Organ Procurement, 3126 Kirurgia, anestesiologia, tehohoito, radiologia, Organ Transplantation, Tissue Donors
Published
2020

32. Randomised sham-controlled double-blind trial evaluating remote ischaemic preconditioning in solid organ transplantation: a study protocol for the RIPTRANS trial

Author

Uutela, Aki, primary, Helanterä, Ilkka, additional, Lemström, Karl, additional, Passov, Arie, additional, Syrjälä, Simo, additional, Åberg, Fredrik, additional, Mäkisalo, Heikki, additional, Nordin, Arno, additional, Lempinen, Marko, additional, and Sallinen, Ville, additional

Published
2020
Full Text
View/download PDF

33. Relative and absolute cancer risks among Nordic kidney transplant recipients—a population‐based study

Author

Benoni, Henrik, primary, Eloranta, Sandra, additional, Dahle, Dag O., additional, Svensson, My H.S., additional, Nordin, Arno, additional, Carstens, Jan, additional, Mjøen, Geir, additional, Helanterä, Ilkka, additional, Hellström, Vivan, additional, Enblad, Gunilla, additional, Pukkala, Eero, additional, Sørensen, Søren S., additional, Lempinen, Marko, additional, and Smedby, Karin E., additional

Published
2020
Full Text
View/download PDF

34. Letermovir treatment for CMV infection in kidney and pancreas transplantation: A valuable option for complicated cases.

Author

Ortiz, Fernanda, Lempinen, Marko, Aaltonen, Sari, Koivuviita, Niina, and Helanterä, Ilkka

Subjects
*PANCREAS transplantation, *CYTOMEGALOVIRUS diseases, *KIDNEY transplantation, *TRANSPLANTATION of organs, tissues, etc., *ELECTRONIC health records, *INTRA-abdominal infections, *VIRAL encephalitis
Abstract

Cytomegalovirus (CMV) infection remains a major challenge in solid organ transplantation. Ganciclovir has changed the prognosis, but with the expense of possible viral resistance. New antiviral drugs, such as letermovir, have not been studied sufficiently in kidney and pancreas transplant recipients. We reviewed abdominal organ transplants recipients with CMV infection from the national transplant registry and identified patients treated with letermovir from electronic medical records. We report on letermovir treatment in one kidney and three simultaneous pancreas and kidney (SPK) transplant patients with refractory or ganciclovir‐resistant CMV infection (UL54/ UL97 mutation). In SPK patients, persistent leukopenia undermined immunosuppressive and antiviral treatment, favoring life‐threatening bacterial infections or ganciclovir resistance. All patients achieved viral clearance after letermovir monotherapy of 1.5–6 months. Letermovir was well tolerated and leukopenia resolved. Adjustments of calcineurin inhibitor doses were challenging. One acute rejection occurred because of under immunosuppression. After the end of treatment, recurrent low‐grade CMV‐DNAemia was common requiring reinitiating antiviral therapy to achieve viral clearance. To conclude, letermovir was a well‐tolerated valuable option for the treatment of refractory or resistant CMV infection in kidney and pancreas transplantation. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

40. Munuaisensiirtolistalle pääsee nyt ilman edeltävää dialyysihoitoa

Author

Finne, Patrik, Helanterä, Ilkka, Lempinen, Marko, Nefrologian yksikkö, Sisätautien osasto, Clinicum, IV kirurgian klinikka, and HUS Vatsakeskus

Subjects
+pathology, Time Factors, Waiting Lists, Renal Dialysis, Cost-Benefit Analysis, 3126 Kirurgia, anestesiologia, tehohoito, radiologia, Transplants, Kidney, Kidney Transplantation, Tissue Donors
Abstract

Odotusajan lyheneminen vaikuttaisi suotuisasti potilaiden elämään.

Published
2019

44. Kidney transplant outcomes from older deceased donors: A paired kidney analysis by the ERA-EDTA Registry

Author

Pippias, Maria, Jager, Kitty J., Caskey, Fergus, Casula, Anna, Erlandsson, Helen, Finne, Patrik, Heaf, James, Heinze, Georg, Hoitsma, Andries, Kramar, Reinhard, Lempinen, Marko, Magaz, Angela, Midtvedt, Karsten, Mumford, Lisa L., Pascual, Julio, Prütz, Karl G., Sørensen, Søren S., Traynor, Jamie P., Massy, Ziad A., Ravanan, Rommel, Stel, Vianda S., APH - Quality of Care, APH - Aging & Later Life, Medical Informatics, APH - Global Health, and ACS - Pulmonary hypertension & thrombosis

Abstract

As the median age of deceased kidney donors rises, updated knowledge of transplant outcomes from older deceased donors in differing donor-recipient age groups is required. Using ERA-EDTA Registry data we determined survival outcomes of kidney allografts donated from the same older deceased donor (55-70 years), and transplanted into one recipient younger and one recipient of similar age to the donor. The recipient pairs were divided into two groups: group 1; younger (median age: 52 years) and older (60 years), and group 2; younger (41 years) and older (60 years). 1,410 adults were transplanted during 2000-2007. Compared to the older recipients the mean number of functioning graft years at 10-years was six months longer in the group 1 and group 2 younger recipients (p

Published
2018

49. Young deceased donor kidneys show a survival benefit over older donor kidneys in transplant recipients aged 20–50 years: a study by the ERA–EDTA Registry

Author

Pippias, Maria, primary, Jager, Kitty J, additional, Åsberg, Anders, additional, Berger, Stefan P, additional, Finne, Patrik, additional, Heaf, James G, additional, Kerschbaum, Julia, additional, Lempinen, Marko, additional, Magaz, Ángela, additional, Massy, Ziad A, additional, and Stel, Vianda S, additional

Published
2018
Full Text
View/download PDF

50. Munuais- ja haimansiirrot - uusia keinoja jonojen lyhentämiseksi?

Author

Helanterä, Ilkka, Ekstrand, Agneta, Lempinen, Marko, Clinicum, Kirurgian osasto, IV kirurgian klinikka, Nefrologian yksikkö, Sisätautien osasto, and HUS Vatsakeskus

Subjects
3121 Yleislääketiede, sisätaudit ja muut kliiniset lääketieteet, Waiting Lists, 3126 Kirurgia, anestesiologia, tehohoito, radiologia, Pancreas Transplantation, Kidney Transplantation, Tissue Donors, Donor Selection, +statistics & numerical data
Abstract

Teema : elinsiirrot. English summary

Published
2017

Catalog

Books, media, physical & digital resources
See catalog results